Cocaine exposure modulates dopamine and adenosine signaling in the fetal brain

Neuropharmacology

Volumn 58, Issue 2, 2010, Pages 436-443

  Kubrusly, Regina C C ^a,b   Bhide, Pradeep G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Adenosine; Brain development; Cocaine; Dopamine

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE TRANSPORTER; CARRIER PROTEINS AND BINDING PROTEINS; COCAINE; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; EMBRYO; FEMALE; MOUSE; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; BRAIN; CEREBRAL CORTEX; COCAINE; CORPUS STRIATUM; CYCLIC AMP; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; MICE; NUCLEOSIDE TRANSPORT PROTEINS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION;

EID: 72049125334     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.09.007     Document Type: Article

References (48)

1. Akbari H.M., Kramer H.K., Whitaker-Azmitia P.M., Spear L.P., and Azmitia E.C. Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res. 572 (1992) 57-63
2. Araki K.Y., Sims J.R., and Bhide P.G. Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development. Brain Res. 1156 (2007) 31-45
3. Bhide P.G. Dopamine, cocaine and the development of cerebral cortical cytoarchitecture: a review of current concepts. Semin. Cell Dev. Biol. 20 (2009) 395-402
4. Bishnoi M., Chopra K., and Kulkarni S.K. Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia. Pharmacol. Rep. 59 (2007) 181-191
5. Chasnoff I.J., Griffith D.R., MacGregor S., Dirkes K., and Burns K.A. Temporal patterns of cocaine use in pregnancy. Perinatal outcome. J. Am. Med. Assoc. 261 (1989) 1741-1744
6. Chasnoff I.J., Lewis D.E., Griffith D.R., and Willey S. Cocaine and pregnancy: clinical and toxicological implications for the neonate. Clin. Chem. 35 (1989) 1276-1278
7. Chen J.F., Beilstein M., Xu Y.H., Turner T.J., Moratalla R., Standaert D.G., Aloyo V.J., Fink J.S., and Schwarzschild M.A. Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors. Neuroscience 97 (2000) 195-204
8. Chiriboga C.A., Bateman D.A., Brust J.C., and Hauser W.A. Neurologic findings in neonates with intrauterine cocaine exposure. Pediatr. Neurol. 9 (1993) 115-119
9. Chiriboga C.A., Starr D., Kuhn L., and Wasserman G.A. Prenatal cocaine exposure and prolonged focus attention. Poor infant information processing ability or precocious maturation of attentional systems?. Dev. Neurosci. 31 (2009) 149-158
10. Crandall J.E., Hackett H.E., Tobet S.A., Kosofsky B.E., and Bhide P.G. Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice. Cereb. Cortex 14 (2004) 665-675
11. Crandall J.E., McCarthy D.M., Araki K.Y., Sims J.R., Ren J.Q., and Bhide P.G. Dopamine receptor activation modulates GABA neuron migration from the basal forebrain to the cerebral cortex. J. Neurosci. 27 (2007) 3813-3822
12. de Mello M.C., Ventura A.L., Paes de Carvalho R., Klein W.L., and de Mello F.G. Regulation of dopamine- and adenosine-dependent adenylate cyclase systems of chicken embryo retina cells in culture. Proc. Natl. Acad. Sci. U. S. A. 79 (1982) 5708-5712
13. Delaney-Black V., Covington C., Ostrea Jr. E., Romero A., Baker D., Tagle M.T., Nordstrom-Klee B., Silvestre M.A., Angelilli M.L., Hack C., and Long J. Prenatal cocaine and neonatal outcome: evaluation of dose-response relationship. Pediatrics 98 (1996) 735-740
14. Eyler F.D., Warner T.D., Behnke M., Hou W., Wobie K., and Garvan C.W. Executive functioning at ages 5 and 7 years in children with prenatal cocaine exposure. Dev. Neurosci. 31 (2009) 121-136
15. Ferre S., Ciruela F., Woods A.S., Lluis C., and Franco R. Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci. 30 (2007) 440-446
16. Friedman E., Yadin E., and Wang H.Y. Effect of prenatal cocaine on dopamine receptor-G protein coupling in mesocortical regions of the rabbit brain. Neuroscience 70 (1996) 739-747
17. Fuxe K., Ferre S., Genedani S., Franco R., and Agnati L.F. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol. Behav. 92 (2007) 210-217
18. Fuxe K., Marcellino D., Rivera A., Diaz-Cabiale Z., Filip M., Gago B., Roberts D.C., Langel U., Genedani S., Ferraro L., de la Calle A., Narvaez J., Tanganelli S., Woods A., and Agnati L.F. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev. 58 (2008) 415-452
19. Gilman A.G. A protein binding assay for adenosine 3′:5′-cyclic monophosphate. Proc. Natl. Acad. Sci. U. S. A. 67 (1970) 305-312
20. Jones L.B., Stanwood G.D., Reinoso B.S., Washington R.A., Wang H.Y., Friedman E., and Levitt P. In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J. Neurosci. 20 (2000) 4606-4614
21. Kaufman M.H. The Atlas of Mouse Development (1992), Academic Press, New York
22. Kosofsky B.E., Wilkins A.S., Gressens P., and Evrard P. Transplacental cocaine exposure: a mouse model demonstrating neuroanatomic and behavioral abnormalities. J. Child Neurol. 9 (1994) 234-241
23. Kosofsky B.E., and Wilkins A.S. A mouse model of transplacental cocaine exposure. Clinical implications for exposed infants and children. Ann. N. Y. Acad. Sci. 846 (1998) 248-261
24. Levitt P., Harvey J.A., Friedman E., Simansky K., and Murphy E.H. New evidence for neurotransmitter influences on brain development. Trends Neurosci. 20 (1997) 269-274
25. Marcellino D., Roberts D.C., Navarro G., Filip M., Agnati L., Lluis C., Franco R., and Fuxe K. Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal. Brain Res. 1143 (2007) 208-220
26. Matsuzawa H., and Nirenberg M. Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 3472-3476
27. Mayes L.C. Developing brain and in utero cocaine exposure: effects on neural ontogeny. Dev. Psychopathol. 11 (1999) 685-714
28. Meyer J.S., Shearman L.P., Collins L.M., and Maguire R.L. Cocaine binding sites in fetal rat brain: implications for prenatal cocaine action. Psychopharmacology 112 (1993) 445-451
29. Monsma F.J., Mahan L.C., McVittie L.D., Gerfen C.R., and Sibley D.R. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 6723-6727
30. Ohtani N., Goto T., Waeber C., and Bhide P.G. Dopamine modulates cell cycle in the lateral ganglionic eminence. J. Neurosci. 23 (2003) 2840-2850
31. Popolo M., McCarthy D.M., and Bhide P.G. Influence of dopamine on precursor cell proliferation and differentiation in the embryonic mouse telencephalon. Dev. Neurosci. 26 (2004) 229-244
32. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219-1223
33. Ritz M.C., Cone E.J., and Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci. 46 (1990) 635-645
34. Robinson S.W., and Caron M.G. Chimeric D2/D3 dopamine receptors efficiently inhibit adenylyl cyclase in HEk 293 cells. J. Neurochem. 67 (1996) 212-219
35. Schinelli S., Paolillo M., and Corona G.L. Opposing actions of D1- and D2-dopamine receptors on arachidonic acid release and cyclic AMP production in striatal neurons. J. Neurochem. 62 (1994) 944-949
36. Schwarzschild M.A., Agnati L., Fuxe K., Chen J.-F., and Morelli M. Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci. 29 (2006) 647-654
37. Shearman L.P., and Weaver D.R. Distinct pharmacological mechanisms leading to c-fos gene expression in the fetal suprachiasmatic nucleus. J. Biol. Rhythms 16 (2001) 531-540
38. Shen H.Y., Coelho J.E., Ohtsuka N., Canas P.M., Day Y.J., Huang Q.Y., Rebola N., Yu L., Boison D., Cunha R.A., Linden J., Tsien J.Z., and Chen J.F. A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs. J. Neurosci. 28 (2008) 2970-2975
39. Simansky K., and Kachelries W.J. Prenatal exposure to cocaine selectively disrupts motor responses to d-amphetamine in young and mature rabbits. Neuropharmacology 35 (1996) 71-78
40. Soria G., Castane A., Ledent C., Parmentier M., Maldonado R., and Valverde O. The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine. Neuropsychopharmacology 31 (2006) 978-987
41. Theiler K. The House Mouse. Development and Normal Stages from Fertilization to 4 Weeks of Age (1972), Springer, Berlin
42. Unterwald E.M., Cox B.M., Kreek M.J., Cote T.E., and Izenwasser S. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse 15 (1993) 33-38
43. Unterwald E.M., Ivkovic S., Cuntapay M., Stroppolo A., Guinea B., and Ehrlich M.E. Prenatal exposure to cocaine decreases adenylyl cyclase activity in embryonic mouse striatum. Brain Res. Dev. Brain Res. 147 (2003) 67-75
44. Wang H.Y., Runyan S., Yadin E., and Friedman E. Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins. J. Pharmacol. Exp. Ther. 273 (1995) 492-498
45. Wang X.-H., Levitt P., Grayson D.R., and Murphy E.H. Intrauterine cocaine exposure of rabbits: persistent elevation of GABA-immunoreactive neurons in anterior cingulate cortex but not visual cortex. Brain Res. 689 (1995) 32-46
46. Weaver D.R. A2a adenosine receptor gene expression in developing rat brain. Brain Res. Mol. Brain Res. 20 (1993) 313-327
47. Wilkins A.S., Genova L.M., Posten W., and Kosofsky B.E. Transplacental cocaine exposure 1: a rodent model. Neurotoxicol. Teratol. 20 (1998) 215-226
48. Zhen X., Torres C., Wang H.Y., and Friedman E. Prenatal exposure to cocaine disrupts D1A dopamine receptor function via selective inhibition of protein phosphatase 1 pathway in rabbit frontal cortex. J. Neurosci. 21 (2001) 9160-9167